Skip to main content
Log in

Brentuximab vedotin

Neutropenia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Aguiar-Bujanda D, et al. Early and sustained remission with brentuximab vedotin in a case of disseminated cutaneous relapse from systemic anaplastic large cell lymphoma refractory to chemotherapy. European Journal of Dermatology 27: 671-673, No. 6, Nov-Dec 2017. Available from: URL: http://doi.org/10.1684/ejd.2017.3149 - Spain

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brentuximab vedotin. Reactions Weekly 1688, 47 (2018). https://doi.org/10.1007/s40278-018-41682-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-41682-6

Navigation